Literature DB >> 3855357

Familial hypokalemic periodic paralysis. 50-year follow-up of a large family.

O J Buruma, G T Bots, L N Went.   

Abstract

A large family with hypokalemic periodic paralysis was reexamined after 50 years. Two new cases were found in the third generation and 12 in the fourth generation. This family now includes 28 affected patients in four generations. The reexamination ascertained the presence of permanent muscle weakness (PMW) in all investigated affected sibs. This fact, and the fact that indications of the presence of PMW without paralytic attacks were found in only one subject, is strong evidence that both are manifestations of the same more or less fully penetrant dominant gene. A linkage study in this family could not localize the gene on the human genome, but close linkage with 25 genetic marker systems could be excluded.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3855357     DOI: 10.1001/archneur.1985.04060010034012

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  4 in total

1.  Familial hypokalaemic periodic paralysis in Finland.

Authors:  I M Kantola; L T Tarssanen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-04       Impact factor: 10.154

2.  Improvement of muscle strength in familial hypokalaemic periodic paralysis with acetazolamide.

Authors:  T P Links; M J Zwarts; H J Oosterhuis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-09       Impact factor: 10.154

3.  A case report and review of hypokalemic paralysis secondary to renal tubular acidosis.

Authors:  Nilzete Liberato Bresolin; Eugênio Grillo; Vera Regina Fernandes; Francisca Lígia Cirilo Carvalho; José Eduardo Coutinho Goes; Ronaldo José Melo da Silva
Journal:  Pediatr Nephrol       Date:  2005-03-17       Impact factor: 3.714

4.  SCP2 variant is associated with alterations in lipid metabolism, brainstem neurodegeneration, and testicular defects.

Authors:  Melanie Galano; Shereen Ezzat; Vassilios Papadopoulos
Journal:  Hum Genomics       Date:  2022-08-22       Impact factor: 6.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.